×
About 1,833 results

ALLMedicine™ Brugada Syndrome Center

Research & Reviews  686 results

dST-Tiso Interval, a Novel Electrocardiographic Marker of Ventricular Arrhythmia Induci...
https://doi.org/10.1016/j.amjcard.2021.08.014
The American Journal of Cardiology; Iacopino S, Chierchia GB et. al.

Sep 11th, 2021 - The aim of this study was to investigate the reliability of a novel electrocardiographic (ECG) marker in predicting ventricular arrhythmia (VA) inducibility in individuals with drug-induced Brugada syndrome (BrS) type I pattern. Consecutive patien...

Brugada syndrome unmasked by left ventricle posteromedial papillary muscle ventricular ...
https://doi.org/10.1016/j.jelectrocard.2021.08.021
Journal of Electrocardiology; Pinos J, Leiria TLL et. al.

Sep 11th, 2021 - A 46-year-old man presented with left ventricle posteromedial papillary muscle ventricular tachycardia, presyncope, and a type-1 Brugada pattern on the post-electrical cardioversion electrocardiogram. There was a probability of a Brugada syndrome ...

Role of subcutaneous Implantable Loop Recorder for the diagnosis of arrhythmias in Brug...
https://doi.org/10.1016/j.hrthm.2021.08.034
Heart Rhythm; Scrocco C, Ben-Haim Y et. al.

Sep 7th, 2021 - Experience with implantable loop recorders (ILR) in Brugada Syndrome (BrS) is limited. We sought to evaluate the indications and yield of ILR monitoring in a single-centre BrS registry. Demographic, clinical and follow-up data of BrS patients with...

Genotype-Phenotype Correlation of SCN5A Genotype in Patients With Brugada Syndrome and ...
https://doi.org/10.1161/CIRCGEN.120.003222
Circulation. Genomic and Precision Medicine; Milman A, Behr ER et. al.

Sep 1st, 2021 - Brugada syndrome (BrS) is associated with mutations in the cardiac sodium channel gene, SCN5A. However, genetic studies of patients with BrS with arrhythmic events have been limited. We sought to compare various clinical, ECG, and electrophysiolog...

A Deep Learning-enabled Electrocardiogram Model for the Identification of a Rare Inheri...
https://doi.org/10.1016/j.cjca.2021.08.014
The Canadian Journal of Cardiology; Liu CM, Liu CL et. al.

Aug 31st, 2021 - Brugada syndrome is a major cause of sudden cardiac death in young people with a distinctive electrocardiogram (ECG) feature. We aimed to develop a deep learning-enabled ECG model for automatic screening Brugada syndrome to identify these patients...

see more →

Drugs  2 results see all →

News  44 results

Lamictal (lamotrigine): Drug Safety Communication - Studies Show Increased Risk of Heart Rhythm Problems in Patients with Heart Disease | FDA
https://www.fda.gov/safety/medical-product-safety-information/lamictal-lamotrigine-drug-safety-communication-studies-show-increased-risk-heart-rhythm-problems

[Posted 03/31/2021]  AUDIENCE: Patient, Health Professional, Pharmacy, Neurology, Cardiology, Psychiatry  ISSUE: An FDA review of study findings showed a potential increased risk of heart rhythm problems, called arrhythmias, in patients with heart...

New Model Quantifies Cardiac Arrest Risk in Brugada Syndrome
https://www.medscape.com/viewarticle/940327

Nov 4th, 2020 - NEW YORK (Reuters Health) - A new risk stratification model for patients with Brugada syndrome (BrS) is based on four risk factors for ventricular arrhythmias/sudden cardiac death (VA/SCD) and can inform the need for an implantable cardioverter de...

New Model Quantifies Cardiac Arrest Risk in Brugada Syndrome
https://www.staging.medscape.com/viewarticle/940327

Nov 4th, 2020 - NEW YORK (Reuters Health) - A new risk stratification model for patients with Brugada syndrome (BrS) is based on four risk factors for ventricular arrhythmias/sudden cardiac death (VA/SCD) and can inform the need for an implantable cardioverter de...

Study: ICD Therapy Effective in Brugada Syndrome Long-Term
https://www.medpagetoday.com/cardiology/arrhythmias/68461

Oct 10th, 2017 - Action Points Long-term follow-up of Brugada syndrome patients confirmed the efficacy of implanted cardioverter-defibrillator (ICD) devices but also substantial adverse event risk. The predictors of appropriate therapy were a type 1 electrocardiog...

Absorb Stent Off Market; 9/11 Dust Lipid Effects; New AUC in Valvular Imaging
https://www.medpagetoday.com/cardiology/prevention/67813

Sep 11th, 2017 - The Absorb bioresorbable stent will come rapidly off the market worldwide due to poor sales, Abbott announced, although the firm may return with a second-generation device. MedPage Today has the full story here. Kids' exposure to chemical-laden du...

see more →

Patient Education  1 results see all →